Market Tracker

07/26 2:47pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.36
BATS BZX Real-Time Price
As of 2:46pm ET
 -0.005 / -0.37%
Today’s Change
1.13
Today|||52-Week Range
4.62
-51.18%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close1.36
Today’s open1.36
Day’s range1.35 - 1.36
Volume8,545
Average volume (3 months)2,744,516
Market cap$180.5M
Dividend yield--
Data as of 2:46pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...+0.01+0.10%
ATHXAthersys Inc0.000.00%
ZYMEZymeworks Inc-0.14-1.92%
MNOVMediciNova Inc+0.05+0.94%
Data as of 2:47pm ET, 07/26/2017

Financials

Next reporting dateAugust 11, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts